315 related articles for article (PubMed ID: 19324393)
1. Anti-androgen activity of polybrominated diphenyl ethers determined by comparative molecular similarity indices and molecular docking.
Yang W; Mu Y; Giesy JP; Zhang A; Yu H
Chemosphere; 2009 May; 75(9):1159-64. PubMed ID: 19324393
[TBL] [Abstract][Full Text] [Related]
2. Combined 3D-QSAR, molecular docking and molecular dynamics study on thyroid hormone activity of hydroxylated polybrominated diphenyl ethers to thyroid receptors β.
Li X; Ye L; Wang X; Wang X; Liu H; Zhu Y; Yu H
Toxicol Appl Pharmacol; 2012 Dec; 265(3):300-7. PubMed ID: 22982074
[TBL] [Abstract][Full Text] [Related]
3. Molecular docking and comparative molecular similarity indices analysis of estrogenicity of polybrominated diphenyl ethers and their analogues.
Yang W; Liu X; Liu H; Wu Y; Giesy JP; Yu H
Environ Toxicol Chem; 2010 Mar; 29(3):660-8. PubMed ID: 20821492
[TBL] [Abstract][Full Text] [Related]
4. Improved 3D-QSAR analyzes for the predictive toxicology of polybrominated diphenyl ethers with CoMFA/CoMSIA and DFT.
Gu C; Ju X; Jiang X; Yu K; Yang S; Sun C
Ecotoxicol Environ Saf; 2010 Sep; 73(6):1470-9. PubMed ID: 20006384
[TBL] [Abstract][Full Text] [Related]
5. Insights into the structural and conformational requirements of polybrominated diphenyl ethers and metabolites as potential estrogens based on molecular docking.
Yang W; Wei S; Liu H; Yu H
Chemosphere; 2011 Jun; 84(3):328-35. PubMed ID: 21601234
[TBL] [Abstract][Full Text] [Related]
6. Analysis of Ah receptor binding affinities of polybrominated diphenyl ethers via in silico molecular docking and 3D-QSAR.
Li X; Wang X; Shi W; Liu H; Yu H
SAR QSAR Environ Res; 2013 Jan; 24(1):75-87. PubMed ID: 23121134
[TBL] [Abstract][Full Text] [Related]
7. Docking-based 3D-QSAR study for 11beta-HSD1 inhibitors.
Lee JH; Kang NS; Yoo SE
Bioorg Med Chem Lett; 2008 Apr; 18(7):2479-90. PubMed ID: 18314331
[TBL] [Abstract][Full Text] [Related]
8. Molecular docking and 3D QSAR studies on 1-amino-2-phenyl-4-(piperidin-1-yl)-butanes based on the structural modeling of human CCR5 receptor.
Xu Y; Liu H; Niu C; Luo C; Luo X; Shen J; Chen K; Jiang H
Bioorg Med Chem; 2004 Dec; 12(23):6193-208. PubMed ID: 15519163
[TBL] [Abstract][Full Text] [Related]
9. Exploring the binding features of polybrominated diphenyl ethers as estrogen receptor antagonists: docking studies.
Yang WH; Wang ZY; Liu HL; Yu HX
SAR QSAR Environ Res; 2010 Apr; 21(3-4):351-67. PubMed ID: 20544555
[TBL] [Abstract][Full Text] [Related]
10. Molecular docking and three-dimensional quantitative structure-activity relationship studies on the binding modes of herbicidal 1-(substituted phenoxyacetoxy)alkylphosphonates to the E1 component of pyruvate dehydrogenase.
Peng H; Wang T; Xie P; Chen T; He HW; Wan J
J Agric Food Chem; 2007 Mar; 55(5):1871-80. PubMed ID: 17288442
[TBL] [Abstract][Full Text] [Related]
11. In silico investigations of anti-androgen activity of polychlorinated biphenyls.
Li X; Ye L; Wang X; Shi W; Liu H; Qian X; Zhu Y; Yu H
Chemosphere; 2013 Aug; 92(7):795-802. PubMed ID: 23664479
[TBL] [Abstract][Full Text] [Related]
12. Quantitative structure-activity relationship for prediction of the toxicity of polybrominated diphenyl ether (PBDE) congeners.
Wang Y; Zhao C; Ma W; Liu H; Wang T; Jiang G
Chemosphere; 2006 Jul; 64(4):515-24. PubMed ID: 16406101
[TBL] [Abstract][Full Text] [Related]
13. QSAR study of a large set of 3-pyridyl ethers as ligands of the alpha4beta2 nicotinic acetylcholine receptor.
Zhang H; Li H; Ma Q
J Mol Graph Model; 2007 Jul; 26(1):226-35. PubMed ID: 17208024
[TBL] [Abstract][Full Text] [Related]
14. Molecular modeling studies of phenoxypyrimidinyl imidazoles as p38 kinase inhibitors using QSAR and docking.
Ravindra GK; Achaiah G; Sastry GN
Eur J Med Chem; 2008 Apr; 43(4):830-8. PubMed ID: 17706839
[TBL] [Abstract][Full Text] [Related]
15. 3D-QSAR studies of Checkpoint Kinase Weel inhibitors based on molecular docking, CoMFA and CoMSIA.
Yi P; Fang X; Qiu M
Eur J Med Chem; 2008 May; 43(5):925-38. PubMed ID: 17698256
[TBL] [Abstract][Full Text] [Related]
16. Qualitative and quantitative simulation of androgen receptor antagonists: A case study of polybrominated diphenyl ethers.
Wu Y; Shi W; Xia P; Zhang X; Yu H
Sci Total Environ; 2017 Dec; 603-604():495-501. PubMed ID: 28641189
[TBL] [Abstract][Full Text] [Related]
17. Structural basis for androgen receptor agonists and antagonists: interaction of SPEED 98-listed chemicals and related compounds with the androgen receptor based on an in vitro reporter gene assay and 3D-QSAR.
Tamura H; Ishimoto Y; Fujikawa T; Aoyama H; Yoshikawa H; Akamatsu M
Bioorg Med Chem; 2006 Nov; 14(21):7160-74. PubMed ID: 16876421
[TBL] [Abstract][Full Text] [Related]
18. Three-dimensional structure-activity relationships of nonsteroidal ligands in complex with androgen receptor ligand-binding domain.
Söderholm AA; Lehtovuori PT; Nyrönen TH
J Med Chem; 2005 Feb; 48(4):917-25. PubMed ID: 15715462
[TBL] [Abstract][Full Text] [Related]
19. Binding interaction analysis of the active site and its inhibitors for neuraminidase (N1 subtype) of human influenza virus by the integration of molecular docking, FMO calculation and 3D-QSAR CoMFA modeling.
Zhang Q; Yang J; Liang K; Feng L; Li S; Wan J; Xu X; Yang G; Liu D; Yang S
J Chem Inf Model; 2008 Sep; 48(9):1802-12. PubMed ID: 18707092
[TBL] [Abstract][Full Text] [Related]
20. Insights into the structural requirements of farnesyltransferase inhibitors as potential anti-tumor agents based on 3D-QSAR CoMFA and CoMSIA models.
Puntambekar DS; Giridhar R; Yadav MR
Eur J Med Chem; 2008 Jan; 43(1):142-54. PubMed ID: 17448576
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
